Inovio Pharmaceuticals
INO
#9821
Rank
NZ$0.13 B
Marketcap
NZ$1.68
Share price
-4.89%
Change (1 day)
-33.21%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$15.01 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is NZ$15.01 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2026)

Total debt by year

Year Total debt Change
2025-12-31NZ$16.17 M-23.12%
2024-12-31NZ$21.03 M-55.96%
2023-12-31NZ$47.76 M-5.44%
2022-12-31NZ$50.51 M4.49%
2021-12-31NZ$48.34 M-10.66%
2020-12-31NZ$54.11 M-63.37%
2019-12-31NZ$0.14 B
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31NZ$16.67 M-20.07%
2008-12-31NZ$20.86 M
2003-12-31NZ$0.5 M1191.63%
2002-12-31NZ$0.03 M-65.96%
2001-12-31NZ$0.11 M
2001-03-31NZ$0.29 M23.62%
2000-03-31NZ$0.23 M28.01%
1999-03-31NZ$0.18 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$94.98 B 632,293.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$81.18 B 540,413.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$110.08 B 732,844.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$38.30 B 254,918.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$84.84 B 564,783.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$43.59 B 290,138.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$1.70 B 11,279.55%๐Ÿ‡บ๐Ÿ‡ธ USA